Community Practice

Latest News


CME Content


An FDA Drug Safety Communication sent to healthcare professionals states that Dasatinib (Sprycel, Bristol-Myers Squibb) may increase the risk of pulmonary arterial hypertension.

AMCP appoints its new CEO

The Academy of Managed Care Pharmacy recently appointed Edith Rosato, RPh, as its new CEO.

FDA has approved sitagliptin and simvastatin (Juvisync, MSD International GmbH Clonmel), a fixed-dose combination prescription medication that contains 2 previously approved medications in 1 tablet for use by adults who need both sitagliptin and simvastatin.

In this section we showcase products and product news that ran up against space limitations or fell outside the parameters of recently featured categories in the print edition. Look for more OTC Product News in upcoming issues of the Community Pharmacists? Report.

FDA is now requiring prescribing information for Reclast (zoledronic acid, Novartis) to include a warning against use of the drug by patients with renal dysfunction.

Nonsteroidal anti-inflammatory drugs (NSAIDs) should be used with caution during pregnancy, as exposure may increase the risk of spontaneous abortion, reported a study published online September 6 in the Canadian Medical Association Journal.

SCRIPT Version 10.6, the standard for e-prescribing and related transactions that the National Council for Prescription Drug Programs has been recommending for several years, will be coming into use in upcoming months.

An FDA advisory panel voted 9-2 (with 1 abstention) to recommend approval for rivaroxaban (Xarelto, Johnson & Johnson and Bayer AG), an oral, once-daily anticoagulant as a treatment to prevent stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Annual flu vaccines are the best way to protect children from life-threatening pneumonia, according to new guidelines from the Pediatric Infectious Diseases Society and the Infectious Disease Society of America.

Morton Pharmacy, a 79-year-old retail pharmacy chain, is selling a majority of its business to Walgreens because of what Morton executives call a difficult business climate for community pharmacies.